SCHEMBL26239688

SCHEMBL26239688

CCCCCCCc1ccc(CC(=O)OC)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.64
CYP4F2 P78329 1/20 0.64
CYP4A11 Q02928 1/20 0.64
HSD17B10 Q99714 2/20 0.56
HPGD P15428 1/20 0.56
ESR1 P03372 2/20 0.55
ADRA2A P08913 2/20 0.55
ADORA3 P0DMS8 2/20 0.55
TACR2 P21452 2/20 0.55
SLC6A2 P23975 2/20 0.55
SLC6A4 P31645 2/20 0.55
SLC6A3 Q01959 2/20 0.55
KDM4E B2RXH2 1/20 0.55
LMNA P02545 1/20 0.55
SHBG P04278 1/20 0.55
TP53 P04637 1/20 0.55
CYP3A4 P08684 1/20 0.55
HSPD1 P10809 1/20 0.55
ADRB3 P13945 1/20 0.55
HTR2C P28335 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23167611 1.00 ALDH1A1 (0.64) ALDH1A1CYP4F2CYP4A11HSD17B10HPGD
SCHEMBL23521630 0.98 ALDH1A1 (0.66) ALDH1A1CYP4F2CYP4A11HSD17B10HPGD
SCHEMBL27473665 0.93 CYP4F2 (0.68) ALDH1A1CYP4F2CYP4A11HSD17B10HPGD
SCHEMBL15586041 0.91 CYP4A11 (0.75) ALDH1A1CYP4F2CYP4A11HSD17B10HPGD
SCHEMBL6803458 0.89 ALDH1A1 (0.58) ALDH1A1CYP4F2CYP4A11HSD17B10HPGD
SCHEMBL11493064 0.87 CYP4A11 (0.75) ALDH1A1CYP4F2CYP4A11HSD17B10HPGD
SCHEMBL26239962 0.86 FAAH (0.55) ALDH1A1HSD17B10ESR1ADRA2AADORA3
SCHEMBL25169991 0.86 FAAH (0.59) ALDH1A1HSD17B10ESR1ADRA2AADORA3
SCHEMBL26239880 0.86 FAAH (0.55) ALDH1A1HSD17B10ESR1ADRA2AADORA3
SCHEMBL27357681 0.86 FAAH (0.55) ALDH1A1HSD17B10ESR1ADRA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024098361-A1 ARTIFICIAL NUCLEIC ACID MOLECULE 斯微(上海)生物科技股份有限公司 2024-05-16 WO disclosed
US-20230263742-A1 A LIPID Stemirna Therapeutics Co., Ltd. (CN) 2023-08-24 US disclosed
US-20230263742-A1 A LIPID Stemirna Therapeutics Co., Ltd. (CN) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230263742-A1 A LIPID CETP, PLIN1, AUP1 ALDH1A1 1643/4885CYP4F2 1444/4885CYP4A11 2063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.